Optic neuritis as an immune-related adverse event of pembrolizumab

被引：0
|
作者：
Nakajima, Isana [1 ,2 ]
Nakaizumi, Tomoko [1 ]
Tsuji, Hideki [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Ophthalmol, Tokyo, Japan
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Ophthalmol, Tokyo 1358555, Japan
来源：
NEUROLOGY AND CLINICAL NEUROSCIENCE | 2024年 / 12卷 / 05期
关键词：
immune checkpoint inhibitor; optic neuritis;
D O I：
10.1111/ncn3.12811
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：325 / 326
页数：2
相关论文
共 50 条
  • [1] Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
    Lima, Gian
    Kahn, Adriana
    Sama, Shashank
    Savage, Jacqueline
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [2] Renal Immune-related Adverse Event of Pembrolizumab Masked by Pemetrexed
    Nagase, Koya
    Murai, Yukari
    Yokoyama-Kokuryo, Waka
    Nagasaka, Toru
    Sato, Yuki
    Watanabe, Tsuyoshi
    Ito, Yuki
    Nagase, Fumika
    Fujita, Yoshiro
    INTERNAL MEDICINE, 2024, 63 (02) : 265 - 270
  • [3] Pembrolizumab-caused polyradiculoneuropathy as an immune-related adverse event
    Kurashige, Takashi
    Mito, Mineyo
    Yamamoto, Hideki
    Sugiura, Tomohito
    Onoe, Takashi
    Kuraoka, Kazuya
    Nakano, Kikuo
    Torii, Tsuyoshi
    NEUROPATHOLOGY, 2021, 41 (04) : 266 - 272
  • [4] Secondary Adrenal Insufficiency as an Immune-Related Adverse Event of Pembrolizumab Therapy
    Escano, Lorena
    Desai, Prarthana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [5] Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event
    Thakker, Malvi
    Quadri, Kalimullah
    Desai, Ankuri
    Illyas, Wajiha
    Kim, Min Young
    Desai, Sanket
    Rager, Christina
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (11) : 613 - +
  • [6] Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab
    Nakajima, Isana
    Nakaizumi, Tomoko
    Tsuji, Hideki
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (04): : e388 - e388
  • [7] Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab
    Nakamagoe, Kiyotaka
    Yamada, Takeshi
    Okune, Sho
    Moriwaki, Toshikazu
    Tamaoka, Akira
    ACTA NEUROLOGICA BELGICA, 2021, 121 (05) : 1381 - 1382
  • [8] ADRENOCORTICOTROPIC HORMONE (ACTH) DEFICIENCY WITH PEMBROLIZUMAB THERAPY: AN IMMUNE-RELATED ADVERSE EVENT?
    Udeh, Uba C.
    Ramesh, Navitha
    CHEST, 2022, 162 (04) : 1739A - 1739A
  • [9] Multiple Immune-Related Adverse Event Overlap in Two Patients Treated with Pembrolizumab
    Jenkins, Jessica D.
    Camara-Lemarroy, Carlos
    Joseph, Jeffrey T.
    Brust, Tyson
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2022, 49 (01) : 133 - 135
  • [10] Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab
    Kiyotaka Nakamagoe
    Takeshi Yamada
    Sho Okune
    Toshikazu Moriwaki
    Akira Tamaoka
    Acta Neurologica Belgica, 2021, 121 : 1381 - 1382
12345